Does Rallies track congressional trades in NTLA?

Yes. Rallies tracks politician and congressional stock disclosures for NTLA, including reported purchases, sales, dates, owners, and trade amounts when available.

Is NTLA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for NTLA. It does not provide personalized investment advice.

NTLA (Intellia) Stock Analysis - Politician Trades

Intellia (NTLA) is a publicly traded Healthcare sector company. As of May 20, 2026, NTLA trades at $12.27 with a market cap of $1.77B and a P/E ratio of -3.48. NTLA moved +2.68% today. Year to date, NTLA is +30.84%; over the trailing twelve months it is +26.78%. Its 52-week range spans $5.90 to $28.25. Analyst consensus is buy with an average price target of $21.06. Rallies surfaces NTLA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded NTLA stock?

Recent politician trading activity in NTLA includes disclosures from Thomas R. Carper, Thomas R. Carper, and Thomas R. Carper. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

NTLA Key Metrics

Key financial metrics for NTLA
Metric	Value
Price	$12.27
Market Cap	$1.77B
P/E Ratio	-3.48
EPS	$-3.53
Dividend Yield	0.00%
52-Week High	$28.25
52-Week Low	$5.90
Volume	3.64M
Avg Volume	0
Revenue (TTM)	$66.09M
Net Income	$-394.60M
Gross Margin	0.00%

Congressional Trades in NTLA

Thomas R. Carper sale (full) NTLA on Aug 25, 2023 (amount: $15.00K) for Spouse.
Thomas R. Carper purchase NTLA on May 22, 2023 (amount: $15.00K) for Spouse.
Thomas R. Carper purchase NTLA on Nov 20, 2020 (amount: $15.00K) for Spouse.

Latest NTLA News

Intellia’s Lonvo-z Cuts Attacks 87%, Initiates BLA Submission and Raises $207M — May 11, 2026
Intellia Raises $180M with 16.7M Shares at $10.75 — Apr 29, 2026
Citigroup Reiterates Outperform as Intellia Files BLA and Seeks $150M — Apr 28, 2026
Intellia Launches $150M Stock Sale as Shares Rally 25% on Phase 3 Catalyst — Apr 27, 2026
Intellia's CRISPR Therapy Cuts HAE Attacks 87%, Targets 2027 Launch — Apr 27, 2026

Recent NTLA Insider Trades

BASTA JAMES sold 1.21K (~$16.69K) on Mar 2, 2026.
Clark Eliana sold 607 (~$8.36K) on Mar 2, 2026.
LEONARD JOHN M sold 34.15K (~$314.48K) on Jan 5, 2026.

NTLA Analyst Consensus

19 analysts cover NTLA: 0 strong buy, 9 buy, 8 hold, 2 sell, 0 strong sell. Consensus rating is buy. Average price target: $21.06.

Common questions about NTLA

Which politicians traded NTLA stock?: Recent politician trading activity in NTLA includes disclosures from Thomas R. Carper, Thomas R. Carper, and Thomas R. Carper. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in NTLA?: Yes. Rallies tracks politician and congressional stock disclosures for NTLA, including reported purchases, sales, dates, owners, and trade amounts when available.
Is NTLA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for NTLA. It does not provide personalized investment advice.